Benchmark Reiterates a 'Buy' on AeroVironment (AVAV); Long-Term Growth Prospects And/Or Acquisition Target
Get Alerts AVAV Hot Sheet
Price: $181.13 -6.06%
Rating Summary:
20 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
20 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Benchmark reiterates a 'Buy' on AeroVironment (NASDAQ: AVAV) price target of $38.00.
Analyst, Josephine Millward, said, "AVAV has a strong balance sheet with $200 million in cash ($8.95 share). Valuation remains compelling based on AV's above average, double-digit, long-term growth prospects from a portfolio of innovative technology solutions at various stages of customer adoption. We also believe AVAV becomes a highly attractive acquisition target in defense industry consolidation when the Switchblade or Global Observer moves into production in the coming years."
For an analyst ratings summary and ratings history on AeroVironment click here. For more ratings news on AeroVironment click here.
Shares of AeroVironment closed at $25.85 yesterday.
Analyst, Josephine Millward, said, "AVAV has a strong balance sheet with $200 million in cash ($8.95 share). Valuation remains compelling based on AV's above average, double-digit, long-term growth prospects from a portfolio of innovative technology solutions at various stages of customer adoption. We also believe AVAV becomes a highly attractive acquisition target in defense industry consolidation when the Switchblade or Global Observer moves into production in the coming years."
For an analyst ratings summary and ratings history on AeroVironment click here. For more ratings news on AeroVironment click here.
Shares of AeroVironment closed at $25.85 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share